{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:08Z","timestamp":1791300488078,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T00:00:00Z","timestamp":1335744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T00:00:00Z","timestamp":1335744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                        <jats:title>Introduction\n<\/jats:title>\n                        <jats:p>Autoantibodies in patients with polymyositis\/dermatomyositis (PM\/DM) are associated with unique subsets, clinical course and outcome. Anti-MJ antibodies, which recognize the nuclear protein NXP-2\/MORC3, are reported in ~25% of juvenile DM. Prevalence and clinical significance of anti-MJ antibodies in adult Italian PM\/DM patients were studied.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods\n<\/jats:title>\n                        <jats:p>Sera from 58 consecutive adult Italian PM\/DM patients were analyzed by immunoprecipitation of <jats:sup>35<\/jats:sup>S-labeled K562 cells extract, ELISA (anti-MJ, Jo-1), Western blot and indirect immunofluorescence. Clinical associations were analyzed using information from medical charts.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results\n<\/jats:title>\n                        <jats:p>Anti-MJ antibodies were the most prevalent specificity (17%) found mainly in DM (30%, 8 cases) vs 8% of PM (2 cases, <jats:italic>P<\/jats:italic> = 0.02). Comparing 10 anti-MJ (+) vs 48 anti-MJ (-) cases, DM was more common (<jats:italic>P<\/jats:italic> = 0.03), and age at onset was younger in anti-MJ (+) (<jats:italic>P<\/jats:italic> = 0.0006). In anti-MJ (+), heliotrope rash (<jats:italic>P<\/jats:italic> = 0.01) and calcinosis (<jats:italic>P<\/jats:italic> = 0.09) were more frequent. None of them had heart or lung involvement, or malignancy. Myopathy in anti-MJ (+) patients responded well to therapy and none of them had elevated CPK at last visit (0% vs 25% in anti-MJ (-)). Only 60% of anti-MJ (+) showed immunofluorescent nuclear dots staining, despite PML localization of NXP-2\/MORC3.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions\n<\/jats:title>\n                        <jats:p>Anti-MJ antibodies are the most frequent specificity in our cohort of adult Italian PM\/DM. Anti-MJ (+) were associated with young onset DM, calcinosis, no internal organ involvement and good response of myopathy to therapy. Anti-MJ reported in juvenile DM is also found in adult PM\/DM, and could be a new useful biomarker.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3822","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T16:15:21Z","timestamp":1335802521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis"],"prefix":"10.1186","volume":"14","author":[{"given":"Angela","family":"Ceribelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Taraborelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Quinzanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason YF","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad A","family":"Pauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward KL","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,30]]},"reference":[{"key":"3576_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0889-857X(02)00032-7","volume":"28","author":"IN Targoff","year":"2002","unstructured":"Targoff IN: Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002, 28: 859-890. 10.1016\/S0889-857X(02)00032-7. viii","journal-title":"Rheum Dis Clin North Am"},{"key":"3576_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2217\/ijr.10.48","volume":"5","author":"R Nakashima","year":"2010","unstructured":"Nakashima R, Mimori T: Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies. Int J Clin Rheumatol. 2010, 5: 523-536. 10.2217\/ijr.10.48.","journal-title":"Int J Clin Rheumatol"},{"key":"3576_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","volume":"7","author":"M Zong","year":"2011","unstructured":"Zong M, Lundberg IE: Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol. 2011, 7: 297-306. 10.1038\/nrrheum.2011.39.","journal-title":"Nat Rev Rheumatol"},{"key":"3576_CR4","first-page":"S139","volume":"40","author":"CV Oddis","year":"1997","unstructured":"Oddis CV, Fertig N, Goel A, Espada G, Confalone Gregorian M, Maldonado Cocco JA, Londino AV: Clinical and serological characterization of the anti-MJ antibody in childhood myositis. Arthritis Rheum. 1997, 40: S139-","journal-title":"Arthritis Rheum"},{"key":"3576_CR5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, Cooper RG, Oddis CV, Ramanan AV, Davidson JE, McHugh NJ: Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum. 2009, 60: 1807-1814. 10.1002\/art.24547.","journal-title":"Arthritis Rheum"},{"key":"3576_CR6","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3899\/jrheum.090461","volume":"36","author":"G Espada","year":"2009","unstructured":"Espada G, Maldonado Cocco JA, Fertig N, Oddis CV: Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J Rheumatol. 2009, 36: 2547-2551. 10.3899\/jrheum.090461.","journal-title":"J Rheumatol"},{"key":"3576_CR7","first-page":"S787","volume":"56","author":"IN Targoff","year":"2007","unstructured":"Targoff IN, Trieu EP, Levy-Neto M, Fertig N, Oddis CV: Sera with autoantibodies to the MJ antigen react with NXP2. Arthritis Rheum. 2007, 56: S787-","journal-title":"Arthritis Rheum"},{"key":"3576_CR8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1242\/jcs.063586","volume":"123","author":"Y Mimura","year":"2010","unstructured":"Mimura Y, Takahashi K, Kawata K, Akazawa T, Inoue N: Two-step colocalization of MORC3 with PML nuclear bodies. J Cell Sci. 2010, 123: 2014-2024. 10.1242\/jcs.063586.","journal-title":"J Cell Sci"},{"key":"3576_CR9","doi-asserted-by":"publisher","first-page":"20611","DOI":"10.1074\/jbc.M201440200","volume":"277","author":"Y Kimura","year":"2002","unstructured":"Kimura Y, Sakai F, Nakano O, Kisaki O, Sugimoto H, Sawamura T, Sadano H, Osumi T: The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains. J Biol Chem. 2002, 277: 20611-20617. 10.1074\/jbc.M201440200.","journal-title":"J Biol Chem"},{"key":"3576_CR10","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1091\/mbc.E06-08-0747","volume":"18","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Yoshida N, Murakami N, Kawata K, Ishizaki H, Tanaka-Okamoto M, Miyoshi J, Zinn AR, Shime H, Inoue N: Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol Biol Cell. 2007, 18: 1701-1709. 10.1091\/mbc.E06-08-0747.","journal-title":"Mol Biol Cell"},{"key":"3576_CR11","first-page":"S304","volume":"60","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, Chinoy H, Venkovsky J, Allard SA, Gordon PA, Cooper RG, McHugh NJ: Autoantibodies to the p140 autoantigen NXP-2 in adult dermatomyositis. Arthritis Rheum. 2009, 60: S304-","journal-title":"Arthritis Rheum"},{"key":"3576_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","volume":"71","author":"Y Ichimura","year":"2012","unstructured":"Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y, Inokoshi Y, Kawai K, Kanekura T, Habuchi M, Igarashi A, Sogame R, Hashimoto T, Koga T, Nishino A, Ishiguro N, Sugimoto N, Aoki R, Ando N, Abe T, Kanda T, Kuwana M, Takehara K, Fujimoto M: Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012, 71: 710-13. 10.1136\/annrheumdis-2011-200697.","journal-title":"Ann Rheum Dis"},{"key":"3576_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","volume":"56","author":"A Bohan","year":"1977","unstructured":"Bohan A, Peter JB, Bowman RL, Pearson CM: Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977, 56: 255-286.","journal-title":"Medicine (Baltimore)"},{"key":"3576_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/art.22329","volume":"56","author":"Y Yamasaki","year":"2007","unstructured":"Yamasaki Y, Narain S, Yoshida H, Hernandez L, Barker T, Hahn PC, Sobel ES, Richards HB, Chan EKL, Reeves WH, Satoh M: Autoantibodies to RNA helicase A: A new serological marker of early lupus. Arthritis Rheum. 2007, 56: 596-604. 10.1002\/art.22329.","journal-title":"Arthritis Rheum"},{"key":"3576_CR15","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/ar2000","volume":"8","author":"Y Yamasaki","year":"2006","unstructured":"Yamasaki Y, Narain S, Hernandez L, Barker T, Ikeda K, Segal MS, Richards HB, Chan EK, Reeves WH, Satoh M: Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases. Arthritis Res Ther. 2006, 8: R111-120. 10.1186\/ar2000.","journal-title":"Arthritis Res Ther"},{"key":"3576_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/art.1780400523","volume":"40","author":"C-E Tseng","year":"1997","unstructured":"Tseng C-E, Chan EKL, Miranda E, Gross M, Di Donato F, Buyon JP: The 52-kD protein as a target of intermolecular spreading of the immune response to components of the SS-A\/Ro-SS-B\/La complex. Arthritis Rheum. 1997, 40: 936-944. 10.1002\/art.1780400523.","journal-title":"Arthritis Rheum"},{"key":"3576_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1172\/JCI115003","volume":"87","author":"EK Chan","year":"1991","unstructured":"Chan EK, Hamel JC, Buyon JP, Tan EM: Molecular definition and sequence motifs of the 52-kD component of human SS-A\/Ro autoantigen. J Clin Invest. 1991, 87: 68-76. 10.1172\/JCI115003.","journal-title":"J Clin Invest"},{"key":"3576_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1083\/jcb.147.2.221","volume":"147","author":"AM Ishov","year":"1999","unstructured":"Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF, Maul GG: PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol. 1999, 147: 221-234. 10.1083\/jcb.147.2.221.","journal-title":"J Cell Biol"},{"key":"3576_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","volume":"47","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, Davidson JE, Cooper RG, McHugh NJ: Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford). 2008, 47: 324-328.","journal-title":"Rheumatology (Oxford)"},{"key":"3576_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, Ishiguro N, Ueda-Hayakawa I, Asano Y, Ogawa F, Fujikawa K, Miyagi T, Mabuchi E, Hirose K, Akimoto N, Hatta N, Tsutsui K, Higashi A, Igarashi A, Seishima M, Hasegawa M, Takehara K: Myositis-specific anti-155\/140 autoantibodies target transcriptional intermediary factor 1 family proteins. Arthritis Rheum. 2012, 64: 513-522. 10.1002\/art.33403.","journal-title":"Arthritis Rheum"},{"key":"3576_CR21","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1002\/art.30192","volume":"63","author":"ALY Ceribelli","year":"2011","unstructured":"Ceribelli ALY, Cavazzana I, Franceschini F, Ross SJ, Chan JYF, Pauley BA, Sobel ES, Reeves WH, Chan EKL, et al: Distinctive pattern of myositis-specific autoantibody production between American Caucasian and Italian patients with polymyositis\/dermatomyositis. Arthritis Rheum. 2011, 63: S232-","journal-title":"Arthritis Rheum"},{"key":"3576_CR22","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3899\/jrheum.100316","volume":"37","author":"A Ceribelli","year":"2010","unstructured":"Ceribelli A, Cavazzana I, Franceschini F, Airo P, Tincani A, Cattaneo R, Pauley BA, Chan EK, Satoh M: Anti-Th\/To are common antinucleolar autoantibodies in Italian patients with scleroderma. J Rheumatol. 2010, 37: 2071-2075. 10.3899\/jrheum.100316.","journal-title":"J Rheumatol"},{"key":"3576_CR23","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1073\/pnas.0601066103","volume":"103","author":"A Rosendorff","year":"2006","unstructured":"Rosendorff A, Sakakibara S, Lu S, Kieff E, Xuan Y, DiBacco A, Shi Y, Gill G: NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc Natl Acad Sci USA. 2006, 103: 5308-5313. 10.1073\/pnas.0601066103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3576_CR24","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1002\/art.22862","volume":"56","author":"Z Betteridge","year":"2007","unstructured":"Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N: Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum. 2007, 56: 3132-3137. 10.1002\/art.22862.","journal-title":"Arthritis Rheum"},{"key":"3576_CR25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/BOR.0b013e328313bff4","volume":"20","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ: Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol. 2008, 20: 675-680. 10.1097\/BOR.0b013e328313bff4.","journal-title":"Curr Opin Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3822\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:31:40Z","timestamp":1728383500000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,30]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,4]]}},"alternative-id":["3576"],"URL":"https:\/\/doi.org\/10.1186\/ar3822","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,30]]},"assertion":[{"value":"4 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R97"}}